$OPCH
Option Care Health, Inc.

2020 Q4 Form 10-K Financial Statement

#000101473921000011 Filed on March 11, 2021

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q1 2019 Q4
Revenue $804.7M $705.4M $720.8M
YoY Change 11.64% 48.05% 42.52%
Cost Of Revenue $621.0M $547.4M $545.1M
YoY Change 13.92% 351.32% 349.01%
Gross Profit $183.8M $158.0M $175.6M
YoY Change 4.62% 60.94% 58.24%
Gross Profit Margin 22.84% 22.4% 24.37%
Selling, General & Admin $130.8M $129.3M $143.8M
YoY Change -9.04% 56.16% 989.39%
% of Gross Profit 71.18% 81.81% 81.87%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $17.80M $20.10M $18.90M
YoY Change -5.82% 101.64% 278.0%
% of Gross Profit 9.69% 12.72% 10.76%
Operating Expenses $139.4M $149.4M $161.4M
YoY Change -13.63% 61.05% 168.11%
Operating Profit $44.34M $8.648M $13.97M
YoY Change 217.35% 59.03% 3.14%
Interest Expense -$22.70M $28.09M -$28.80M
YoY Change -21.18% 154.3% 88.24%
% of Operating Profit -51.19% 324.78% -206.11%
Other Income/Expense, Net -$23.00M $8.000K -$300.0K
YoY Change 7566.67% -100.16%
Pretax Income $18.40M -$18.90M -$14.80M
YoY Change -224.32% 84.1% -1.35%
Income Tax $600.0K $1.000M $1.000M
% Of Pretax Income 3.26%
Net Earnings $17.84M -$19.91M -$15.81M
YoY Change -212.83% 436.37% -585.89%
Net Earnings / Revenue 2.22% -2.82% -2.19%
Basic Earnings Per Share $0.10 -$0.11 -$0.09
Diluted Earnings Per Share $0.10 -$0.11 -$0.09
COMMON SHARES
Basic Shares Outstanding 186.8M shares 176.7M shares 705.8M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2020 Q4 2020 Q1 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $99.30M $77.20M $67.10M
YoY Change 47.99% 1254.39% 362.76%
Cash & Equivalents $99.27M $77.24M $67.06M
Short-Term Investments
Other Short-Term Assets $70.80M $47.70M $51.30M
YoY Change 38.01% 178.95% 175.81%
Inventory $158.6M $139.1M $115.9M
Prepaid Expenses
Receivables $328.3M $337.2M $324.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $657.0M $601.3M $558.7M
YoY Change 17.61% 251.45% 19.52%
LONG-TERM ASSETS
Property, Plant & Equipment $121.1M $125.8M $133.2M
YoY Change -9.05% 352.5% 43.01%
Goodwill $1.429B $1.428B $1.426B
YoY Change 0.22% 125.76% 125.39%
Intangibles
YoY Change
Long-Term Investments $17.00M $17.00M $17.00M
YoY Change 0.0% 16.44%
Other Assets $20.82M $21.73M $22.74M
YoY Change -8.44% 1163.82% 47.08%
Total Long-Term Assets $1.990B $2.011B $2.031B
YoY Change -1.99% 372.01% 111.38%
TOTAL ASSETS
Total Short-Term Assets $657.0M $601.3M $558.7M
Total Long-Term Assets $1.990B $2.011B $2.031B
Total Assets $2.647B $2.613B $2.590B
YoY Change 2.24% 337.47% 81.31%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $282.9M $265.7M $221.1M
YoY Change 27.98% 243.03% 17.66%
Accrued Expenses $130.7M $100.9M $99.70M
YoY Change 31.09% 208.56% 175.41%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $9.250M $9.250M $9.250M
YoY Change 0.0% 105.56% 122.89%
Total Short-Term Liabilities $434.0M $379.0M $330.0M
YoY Change 31.52% 227.91% 37.5%
LONG-TERM LIABILITIES
Long-Term Debt $1.115B $1.276B $1.277B
YoY Change -12.69% 151.89% 138.64%
Other Long-Term Liabilities $8.474M $29.70M $15.09M
YoY Change -43.82% 88.64% -9.58%
Total Long-Term Liabilities $1.198B $1.363B $1.353B
YoY Change -11.46% 8556.81% 131.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $434.0M $379.0M $330.0M
Total Long-Term Liabilities $1.198B $1.363B $1.353B
Total Liabilities $1.632B $1.742B $1.683B
YoY Change -3.03% 165.04% 103.87%
SHAREHOLDERS EQUITY
Retained Earnings -$100.0M -$111.9M -$91.96M
YoY Change 8.78% -85.5% 473.46%
Common Stock $1.129B $1.009B $1.008B
YoY Change 11.99% 63.6% 62.74%
Preferred Stock
YoY Change
Treasury Stock (at cost) $2.403M $2.403M $2.403M
YoY Change 0.0% 79.87%
Treasury Stock Shares 383.7K shares 383.7K shares 383.7K shares
Shareholders Equity $1.016B $870.5M $906.8M
YoY Change
Total Liabilities & Shareholders Equity $2.647B $2.613B $2.590B
YoY Change 2.24% 337.47% 81.31%

Cashflow Statement

Concept 2020 Q4 2020 Q1 2019 Q4
OPERATING ACTIVITIES
Net Income $17.84M -$19.91M -$15.81M
YoY Change -212.83% 436.37% -585.89%
Depreciation, Depletion And Amortization $17.80M $20.10M $18.90M
YoY Change -5.82% 101.64% 278.0%
Cash From Operating Activities $25.70M $18.40M $22.90M
YoY Change 12.23% 102.68% 22800.0%
INVESTING ACTIVITIES
Capital Expenditures -$14.00M $5.353M -$15.10M
YoY Change -7.28% -0.26% 235.56%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$14.00M -$5.353M -$15.10M
YoY Change -7.28% 13.15% 268.29%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -52.40M -$2.862M 6.500M
YoY Change -906.15% -5.79% -1725.0%
NET CHANGE
Cash From Operating Activities 25.70M $18.40M 22.90M
Cash From Investing Activities -14.00M -$5.353M -15.10M
Cash From Financing Activities -52.40M -$2.862M 6.500M
Net Change In Cash -40.70M $10.19M 14.30M
YoY Change -384.62% 677.12% -425.0%
FREE CASH FLOW
Cash From Operating Activities $25.70M $18.40M $22.90M
Capital Expenditures -$14.00M $5.353M -$15.10M
Free Cash Flow $39.70M $13.05M $38.00M
YoY Change 4.47% 251.47% 726.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001014739
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2020Q1 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.25
CY2020 dei Document Type
DocumentType
10-K
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Period End Date
DocumentPeriodEndDate
2020-12-31
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity File Number
EntityFileNumber
001-11993
CY2020 dei Entity Registrant Name
EntityRegistrantName
OPTION CARE HEALTH, INC.
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
05-0489664
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
3000 Lakeside Dr.
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 300N
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Bannockburn
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60015
CY2020 dei City Area Code
CityAreaCode
312
CY2020 dei Local Phone Number
LocalPhoneNumber
940-2443
CY2020 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
CY2020 dei Trading Symbol
TradingSymbol
OPCH
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2020 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2020 dei Entity Small Business
EntitySmallBusiness
false
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
473322477 USD
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
179814189 shares
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
99265000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67056000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
328340000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
324416000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
158601000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
115876000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
70806000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
51306000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
657012000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
558654000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121149000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133198000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68795000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63502000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
351052000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
385910000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1428610000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1425542000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
20821000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22741000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1990427000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
2030893000 USD
CY2020Q4 us-gaap Assets
Assets
2647439000 USD
CY2019Q4 us-gaap Assets
Assets
2589547000 USD
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
282913000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
221060000 USD
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
58899000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
45765000 USD
CY2020Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
64075000 USD
CY2019Q4 bios Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
33538000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
18886000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
20391000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
434023000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
330004000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1115103000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1277246000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70776000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
58242000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3339000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
2143000 USD
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
8474000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15085000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1197692000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1352716000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
1631715000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1682720000 USD
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
12500000 shares
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000 shares
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
180178308 shares
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
179794586 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
176975628 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
176591907 shares
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
18000 USD
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
2403000 USD
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1129312000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1008362000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100031000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91955000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11172000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7195000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
906827000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2647439000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2589547000 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3032610000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2310417000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1939791000 USD
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2350346000 USD
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1797418000 USD
CY2018 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1517576000 USD
CY2020 us-gaap Gross Profit
GrossProfit
682264000 USD
CY2019 us-gaap Gross Profit
GrossProfit
512999000 USD
CY2018 us-gaap Gross Profit
GrossProfit
422215000 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
500199000 USD
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
459628000 USD
CY2018 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
345884000 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
71310000 USD
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
53690000 USD
CY2018 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
38062000 USD
CY2020 us-gaap Operating Expenses
OperatingExpenses
571509000 USD
CY2019 us-gaap Operating Expenses
OperatingExpenses
513318000 USD
CY2018 us-gaap Operating Expenses
OperatingExpenses
383946000 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
110755000 USD
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-319000 USD
CY2018 us-gaap Operating Income Loss
OperatingIncomeLoss
38269000 USD
CY2020 us-gaap Interest Expense
InterestExpense
107770000 USD
CY2019 us-gaap Interest Expense
InterestExpense
73724000 USD
CY2018 us-gaap Interest Expense
InterestExpense
45824000 USD
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
3313000 USD
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
2840000 USD
CY2018 us-gaap Investment Income Net
InvestmentIncomeNet
1020000 USD
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-11541000 USD
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-6991000 USD
CY2018 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2233000 USD
CY2020 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-115998000 USD
CY2019 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-77875000 USD
CY2018 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-47037000 USD
CY2020 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-5243000 USD
CY2019 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-78194000 USD
CY2018 us-gaap Income Loss Attributable To Parent
IncomeLossAttributableToParent
-8768000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2833000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2274000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2653000 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6115000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
0 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-259000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3977000 USD
CY2018 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
-234000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-3977000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-8039000 USD
CY2018 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
774000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8039000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
774000 USD
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12053000 USD
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-83959000 USD
CY2018 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5341000 USD
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
180971000 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
156280000 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1196000 USD
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4607000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6115000 USD
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
77896000 USD
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
57869000 USD
CY2018 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
41055000 USD
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
18814000 USD
CY2019 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
19719000 USD
CY2018 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
0 USD
CY2018 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-3595000 USD
CY2020 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-742000 USD
CY2019 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-3269000 USD
CY2018 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
-1123000 USD
CY2020 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
0 USD
CY2019 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
626000 USD
CY2018 us-gaap Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
-3549000 USD
CY2020 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-11545000 USD
CY2019 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-5469000 USD
CY2018 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-72000 USD
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
5517000 USD
CY2019 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
4544000 USD
CY2018 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3107000 USD
CY2020 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
3746000 USD
CY2019 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
0 USD
CY2018 bios Loss On Discontinuance Of Cash Flow Hedge Derivative
LossOnDiscontinuanceOfCashFlowHedgeDerivative
0 USD
CY2020 us-gaap Paid In Kind Interest
PaidInKindInterest
7525000 USD
CY2019 us-gaap Paid In Kind Interest
PaidInKindInterest
12256000 USD
CY2018 us-gaap Paid In Kind Interest
PaidInKindInterest
0 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3313000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2840000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1020000 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
2920000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
500000 USD
CY2018 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2000000 USD
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
4170000 USD
CY2018 us-gaap Share Based Compensation
ShareBasedCompensation
2139000 USD
CY2020 bios Interest Gain Loss On Management Notes Receivable
InterestGainLossOnManagementNotesReceivable
0 USD
CY2019 bios Interest Gain Loss On Management Notes Receivable
InterestGainLossOnManagementNotesReceivable
62000 USD
CY2018 bios Interest Gain Loss On Management Notes Receivable
InterestGainLossOnManagementNotesReceivable
78000 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3250000 USD
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-1500000 USD
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-300000 USD
CY2018 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 USD
CY2020 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
3924000 USD
CY2019 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-82285000 USD
CY2018 us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
21012000 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
42725000 USD
CY2019 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12853000 USD
CY2018 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2965000 USD
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
19500000 USD
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2940000 USD
CY2018 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4715000 USD
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
59215000 USD
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-30856000 USD
CY2018 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
10965000 USD
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
13134000 USD
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2671000 USD
CY2018 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5586000 USD
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
22809000 USD
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-317000 USD
CY2018 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1740000 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
18089000 USD
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
17253000 USD
CY2018 us-gaap Operating Lease Payments
OperatingLeasePayments
0 USD
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
3790000 USD
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
4711000 USD
CY2018 us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-1314000 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127392000 USD
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
39467000 USD
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
24428000 USD
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26875000 USD
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28292000 USD
CY2018 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26276000 USD
CY2020 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2019 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
10000 USD
CY2018 us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
0 USD
CY2020 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2019 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
626000 USD
CY2018 us-gaap Proceeds From Insurance Settlement Investing Activities
ProceedsFromInsuranceSettlementInvestingActivities
0 USD
CY2020 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2019 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
700170000 USD
CY2018 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
10727000 USD
CY2020 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-541000 USD
CY2019 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2018 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
0 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-26334000 USD
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-727826000 USD
CY2018 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-37003000 USD
CY2020 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2019 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
2000000 USD
CY2018 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0 USD
CY2020 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
0 USD
CY2019 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
1310000 USD
CY2018 bios Proceeds From Sale Of Management Notes Receivable
ProceedsFromSaleOfManagementNotesReceivable
0 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
904000 USD
CY2019 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2501000 USD
CY2018 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
118934000 USD
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2020 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
CY2019 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
981050000 USD
CY2018 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
1000000 USD
CY2020 us-gaap Repayments Of Debt
RepaymentsOfDebt
9250000 USD
CY2019 us-gaap Repayments Of Debt
RepaymentsOfDebt
2075000 USD
CY2018 us-gaap Repayments Of Debt
RepaymentsOfDebt
5150000 USD
CY2020 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
174000000 USD
CY2019 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
226738000 USD
CY2018 us-gaap Payments For Deposits Applied To Debt Retirements
PaymentsForDepositsAppliedToDebtRetirements
0 USD
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
149000 USD
CY2019 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
30022000 USD
CY2018 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
CY2020 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
3480000 USD
CY2019 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2018 us-gaap Payments Of Debt Extinguishment Costs
PaymentsOfDebtExtinguishmentCosts
0 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-68849000 USD
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
719024000 USD
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4150000 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32209000 USD
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
30665000 USD
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16725000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67056000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36391000 USD
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53116000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
99265000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
67056000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
36391000 USD
CY2020 us-gaap Interest Paid Net
InterestPaidNet
97640000 USD
CY2019 us-gaap Interest Paid Net
InterestPaidNet
50808000 USD
CY2018 us-gaap Interest Paid Net
InterestPaidNet
47173000 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2884000 USD
CY2019 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2405000 USD
CY2018 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1600000 USD
CY2020 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
26809000 USD
CY2019 us-gaap Operating Lease Payments Use
OperatingLeasePaymentsUse
18992000 USD
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
606105000 USD
CY2018 bios Adjustments To Additional Paid In Capital Stockholders Contribution
AdjustmentsToAdditionalPaidInCapitalStockholdersContribution
0 USD
CY2018 bios Interest On Management Notes Receivable
InterestOnManagementNotesReceivable
78000 USD
CY2018 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2139000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6115000 USD
CY2018 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
774000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
602825000 USD
CY2019 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
387044000 USD
CY2019 bios Interest On Management Notes Receivable
InterestOnManagementNotesReceivable
62000 USD
CY2019 bios Repayment Of Management Notes Receivable
RepaymentOfManagementNotesReceivable
1310000 USD
CY2019 bios Adjustments To Additional Paid In Capital Stockholders Redemption
AdjustmentsToAdditionalPaidInCapitalStockholdersRedemption
2000000 USD
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4170000 USD
CY2019 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
2501000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-8039000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
906827000 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2920000 USD
CY2020 bios Stock Issued Value Restricted Stockand Stock Options Exercised Net Of Tax Withholdings
StockIssuedValueRestrictedStockandStockOptionsExercisedNetOfTaxWithholdings
904000 USD
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
118934000 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3977000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1015724000 USD
CY2020Q4 bios Number Of Service Locations
NumberOfServiceLocations
99 location
CY2020Q4 bios Number Of Infusion Sites
NumberOfInfusionSites
46 site
CY2020Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Premiums And Other Receivables
AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables
0 USD
CY2020Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
79000000.0 USD
CY2019Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
68700000 USD
CY2020Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
35200000 USD
CY2019Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
13900000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17000000.0 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
17000000.0 USD
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3300000 USD
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
2800000 USD
CY2018 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000.0 USD
CY2020 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
3300000 USD
CY2019 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
500000 USD
CY2018 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
2000000.0 USD
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.04
CY2020 bios Business Combination Renewal Term Length
BusinessCombinationRenewalTermLength
P2Y
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3032610000 USD
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2310417000 USD
CY2018 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1939791000 USD
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
1
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
9700000 USD
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6400000 USD
CY2018 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
6300000 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
8900000 USD
CY2019 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6600000 USD
CY2018 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
6300000 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-69000 USD
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2018 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
996000 USD
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-3072000 USD
CY2018 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-2688000 USD
CY2020 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
927000 USD
CY2019 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-3072000 USD
CY2018 us-gaap Federal Income Tax Expense Benefit Continuing Operations
FederalIncomeTaxExpenseBenefitContinuingOperations
-2688000 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1707000 USD
CY2019 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
2074000 USD
CY2018 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
1176000 USD
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
199000 USD
CY2019 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1276000 USD
CY2018 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-1141000 USD
CY2020 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
1906000 USD
CY2019 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
798000 USD
CY2018 us-gaap State And Local Income Tax Expense Benefit Continuing Operations
StateAndLocalIncomeTaxExpenseBenefitContinuingOperations
35000 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2833000 USD
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2274000 USD
CY2018 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-2653000 USD
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.295
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.005
CY2018 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.024
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.299
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.134
CY2018 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.067
CY2019 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
CY2018 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
0.000
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.163
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
0.000
CY2020 bios Effective Income Tax Rate Reconciliation Uncertain Tax Position Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercent
0.000
CY2019 bios Effective Income Tax Rate Reconciliation Uncertain Tax Position Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercent
0.000
CY2018 bios Effective Income Tax Rate Reconciliation Uncertain Tax Position Percent
EffectiveIncomeTaxRateReconciliationUncertainTaxPositionPercent
0.147
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.082
CY2019 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.028
CY2018 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.075
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.022
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.007
CY2018 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.003
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.540
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.029
CY2018 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.303
CY2020Q4 bios Deferred Tax Assets Bad Debt Reserve
DeferredTaxAssetsBadDebtReserve
6907000 USD
CY2019Q4 bios Deferred Tax Assets Bad Debt Reserve
DeferredTaxAssetsBadDebtReserve
12302000 USD
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
4058000 USD
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits
3672000 USD
CY2020Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
39094000 USD
CY2019Q4 us-gaap Deferred Tax Asset Interest Carryforward
DeferredTaxAssetInterestCarryforward
38623000 USD
CY2020Q4 bios Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
22644000 USD
CY2019Q4 bios Deferred Tax Assets Lease Liability
DeferredTaxAssetsLeaseLiability
19462000 USD
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
155922000 USD
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
147749000 USD
CY2020Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
8682000 USD
CY2019Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
5506000 USD
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
237307000 USD
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
227314000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112085000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109531000 USD
CY2020Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
125222000 USD
CY2019Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
117783000 USD
CY2020Q4 bios Deferred Tax Liabilities Accelerated Depreciation
DeferredTaxLiabilitiesAcceleratedDepreciation
12593000 USD
CY2019Q4 bios Deferred Tax Liabilities Accelerated Depreciation
DeferredTaxLiabilitiesAcceleratedDepreciation
10376000 USD
CY2020Q4 bios Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
17186000 USD
CY2019Q4 bios Deferred Tax Liabilities Operating Lease Right Of Use Asset
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAsset
15442000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
67127000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
71204000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
28976000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
20250000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2679000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
2654000 USD
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
128561000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
119926000 USD
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3339000 USD
CY2019Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
2143000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112100000 USD
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2017Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1263000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1373000 USD
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1373000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109531000 USD
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
109531000 USD
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
112085000 USD
CY2020 bios Income Tax Expense Benefit Cares Act
IncomeTaxExpenseBenefitCARESAct
0 USD
CY2018 us-gaap Dilutive Securities
DilutiveSecurities
0 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-8076000 USD
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-75920000 USD
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-6115000 USD
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
180971000 shares
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
156280000 shares
CY2018 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
142614000 shares
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
CY2018 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
30800000 USD
CY2019 us-gaap Operating Lease Expense
OperatingLeaseExpense
25800000 USD
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y8M12D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0518
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
20349000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
211820000 USD
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
84490000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
23770000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
19216000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
15804000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
11684000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
9369000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
30168000 USD
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
110011000 USD
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
89662000 USD
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
29100000 USD
CY2018 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
17300000 USD
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
205639000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
78622000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
121149000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
133198000 USD
CY2020 us-gaap Depreciation
Depreciation
42766000 USD
CY2019 us-gaap Depreciation
Depreciation
31808000 USD
CY2018 us-gaap Depreciation
Depreciation
21483000 USD
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2018 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2017Q4 us-gaap Goodwill
Goodwill
627392000 USD
CY2018 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5077000 USD
CY2018Q4 us-gaap Goodwill
Goodwill
632469000 USD
CY2019 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
793073000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
483059000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
132007000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
97149000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
1425542000 USD
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
3068000 USD
CY2020Q4 us-gaap Goodwill
Goodwill
1428610000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
483059000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
351052000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
385910000 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
35100000 USD
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26100000 USD
CY2018 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
19600000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1115103000 USD
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
32015000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
28338000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
28338000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
28338000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
28338000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
205685000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
351052000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1161531000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
13355000 USD
CY2020Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
23823000 USD
CY2020Q4 us-gaap Long Term Debt
LongTermDebt
1124353000 USD
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1337256000 USD
CY2019Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
20071000 USD
CY2019Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
30689000 USD
CY2019Q4 us-gaap Long Term Debt
LongTermDebt
1286496000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
9250000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1277246000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
9250000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
9250000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
9250000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
9250000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
9250000 USD
CY2020Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
1115281000 USD
CY2020Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1161531000 USD
CY2020Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
11342000 USD
CY2019Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
7285000 USD
CY2020 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-3977000 USD
CY2019 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-8298000 USD
CY2018 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
1008000 USD
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16579000 USD
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-332000 USD
CY2018 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
300000 USD
CY2020Q4 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
11200000 USD
CY2018 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
400000 USD
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
412831 shares
CY2020Q4 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
197735 shares
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0225
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M6D
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
0.4700
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions
0.3000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
1.13
CY2019 us-gaap Shares Paid For Tax Withholding For Share Based Compensation
SharesPaidForTaxWithholdingForShareBasedCompensation
290117 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
383722 shares
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2020Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
705440000 USD
CY2020Q4 us-gaap Gross Profit
GrossProfit
183762000 USD
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
8648000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
23208000 USD
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
740848000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
781609000 USD
CY2020Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
804713000 USD
CY2020Q1 us-gaap Gross Profit
GrossProfit
158029000 USD
CY2020Q2 us-gaap Gross Profit
GrossProfit
166320000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
174153000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
34556000 USD
CY2020Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
44343000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-19910000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-7668000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
1663000 USD
CY2020Q4 us-gaap Net Income Loss
NetIncomeLoss
17839000 USD
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2020Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.10
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.10
CY2019Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
476492000 USD
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
497266000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
615880000 USD
CY2019Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
720779000 USD
CY2019Q1 us-gaap Gross Profit
GrossProfit
98194000 USD
CY2019Q2 us-gaap Gross Profit
GrossProfit
101390000 USD
CY2019Q3 us-gaap Gross Profit
GrossProfit
137773000 USD
CY2019Q4 us-gaap Gross Profit
GrossProfit
175642000 USD
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5438000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-8005000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-11725000 USD
CY2019Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
13973000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-3712000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-13603000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-42794000 USD
CY2019Q4 us-gaap Net Income Loss
NetIncomeLoss
-15811000 USD
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
CY2019Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.09
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.1
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
CY2019Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.09

Files In Submission

Name View Source Status
0001014739-21-000011-index-headers.html Edgar Link pending
0001014739-21-000011-index.html Edgar Link pending
0001014739-21-000011.txt Edgar Link pending
0001014739-21-000011-xbrl.zip Edgar Link pending
bios-20201231.htm Edgar Link pending
bios-20201231.xsd Edgar Link pending
bios-20201231_cal.xml Edgar Link unprocessable
bios-20201231_def.xml Edgar Link unprocessable
bios-20201231_g1.jpg Edgar Link pending
bios-20201231_g2.jpg Edgar Link pending
bios-20201231_htm.xml Edgar Link completed
bios-20201231_lab.xml Edgar Link unprocessable
bios-20201231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
opch-ex1012x20201231x10k.htm Edgar Link pending
opch-ex1013x20201231x10k.htm Edgar Link pending
opch-ex211x20201231x10k.htm Edgar Link pending
opch-ex231x20201231x10k.htm Edgar Link pending
opch-ex311x20201231x10k.htm Edgar Link pending
opch-ex312x20201231x10k.htm Edgar Link pending
opch-ex321x20201231x10k.htm Edgar Link pending
opch-ex322x20201231x10k.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending